Constipation prevention, self-care ability Not Applicable
Conditions
Interventions
The patients were randomly assigned to two groups using block randomisation, with 100 patients in each group. The experimental group received predictive nursing based on routine nursing, which include
Sponsors
Beijing YouAn Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. A confirmed HIV infection / AIDS diagnosis according to the 2021 edition of the Chinese Guidelines for the Diagnosis and Treatment of HIV/AIDS, having received antiretroviral therapy and with a current CD4+ T-cell count of =200 cells/µL 2. Aged =18 years 3. Ability to cooperate with the researchers and complete the study-related procedures and data collection 4. Voluntary participation in the study and signing of an informed consent form
Exclusion criteria
Exclusion criteria: 1. Presence of other anal or colorectal diseases, such as perianal dermatitis or colorectal tumours 2. Recurrent transsphincteric anal fistula 3. Presence of severe diseases such as cardiac, hepatic or renal conditions 4. History of previous anal surgery 5. Presence of mental or psychological disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The effectiveness of constipation prevention was measured using outpatient review, telephone interview and online questionnaire before and after the intervention, according to the Consensus on Traditional Chinese Medicine Diagnosis and Treatment of Constipation (2017) as follows: 1) ineffective: bowel movements less than 3 times per week with hard stools, difficult defaecation or a feeling of incomplete evacuation; 2) effective: bowel movements more than once within 3 days; and 3) highly effective: bowel movements more than once within 2 days. The effective rate of constipation prevention (%) was calculated by dividing the sum of highly effective and effective cases by the total number of cases and multiplying by 100. 2. Self-care ability measured using the Exercise of Self-Care Agency (ESCA) scale before and after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures are assessed using data recorded in patient medical records: 1. Preoperative history of constipation measured by asking the patient whether he has had constipation in the past month before surgery 2. Anal fistula duration 3. Operative time 4. Blood loss 5. Type of surgery 6. CD4 cell counts / viral loads measured using standard laboratory methods and a preoperative blood test 7. Bowel disorders and type of anal fistula | — |
Countries
China
Contacts
Public ContactLi-Li Zhang
Outcome results
None listed